Contract orientation & kick off meeting in support of IDIQ "preclinical pharmacokinetic and pharmacology evaluations of agents being developed for cancer patients." r & d services
Active Awarded Last action
- Contract number
- 75N91021F00001
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7 Part of Mayo Clinic
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,070
Award facts
- Contract value 100% obligated
- $1,070.00 Current and potential, with all options
- Completion date 72% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rochester, MN 55905, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$1,930 | |
| Other Administrative Action | $0 | |
| Original award | $3,000 |
About this award
This federal contract award, valued at $1,070.00, was issued by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center, to provide contract orientation and kick-off meeting support for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract titled "Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients." The contract is structured as a firm-fixed price delivery order and does not have a set-aside designation. Mayo Clinic, as the prime contractor, will leverage its expertise in medical research, clinical trials, and specialized diagnostic services to support the NCI's Experimental Therapeutics program, focusing on the development of cancer therapeutics. This award is part of a larger IDIQ contract vehicle, which allows the NCI to task Mayo Clinic for a range of research and development services related to preclinical pharmacology and pharmacokinetic evaluations of cancer-fighting agents.
Quick answers
Who was awarded contract 75N91021F00001?
75N91021F00001 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on September 27, 2021.
How much is contract 75N91021F00001 worth?
The government has obligated $1,070 on 75N91021F00001.
Is contract 75N91021F00001 an order under another contract?
Yes. 75N91021F00001 is a delivery order under 75N91021D00020, an indefinite delivery contract.
Was contract 75N91021F00001 competed?
The extent of competition for 75N91021F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award